Cite
Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes.
MLA
Geng, Tingting, et al. “Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes.” Diabetes Care, vol. 45, no. 10, Oct. 2022, pp. 2422–29. EBSCOhost, https://doi.org/10.2337/dc22-0717.
APA
Geng, T., Wang, Y., Lu, Q., Zhang, Y.-B., Chen, J.-X., Zhou, Y.-F., Wan, Z., Guo, K., Yang, K., Liu, L., Liu, G., & Pan, A. (2022). Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes. Diabetes Care, 45(10), 2422–2429. https://doi.org/10.2337/dc22-0717
Chicago
Geng, Tingting, Yi Wang, Qi Lu, Yan-Bo Zhang, Jun-Xiang Chen, Yan-Feng Zhou, Zhenzhen Wan, et al. 2022. “Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes.” Diabetes Care 45 (10): 2422–29. doi:10.2337/dc22-0717.